The identification and selection of relevant microbial strains is an important consideration when testing new antimicrobials for CF lung infections. To guide the selection of appropriate strains for robust testing of new anti-infectives, Professor Eshwar Mahenthiralingham from Cardiff University alongside other experts in this area have produced a strain guidance document. The document, published open access in Current Clinical Microbiology Reports, summarises the strain resources available for problematic CF pathogens as well as the selection criteria researchers can use when identifying strains for screening novel anti-infectives.
Access the strain guidance document here.
Visit our biorepository page to access strains, associated data and expertise.
